EMB-07

N/A

Report date: 2026/03/19 17:01:22

Base Information

Drug NameEMB-07
Drug Alias NameEMB-07
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD3Anti-Inactive tyrosine-protein kinase transmembrane receptor ROR1
TargetsT cell surface glycoprotein CD3Inactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Epimab Biotherapeutics, Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesEpimab Biotherapeutics IncShanghai Epimab Biotherapeutics, Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[13] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A